Federal Register #DN 3921

ITC Request for Comments on Melanoma Predictive and Prognostic Test Imports

The U.S. International Trade Commission (ITC) is seeking public comments regarding a complaint about certain melanoma predictive and prognostic tests and their components. - Government Buyer: - U.S. International Trade Commission (ITC) - OEMs and Vendors Mentioned: - Castle Biosciences, Inc. - SkylineDx Holding B.V. - SkylineDx USA, Inc. - Qiagen GmbH - QIAGEN LLC - Products/Services Requested: - Melanoma predictive and prognostic tests - Components of these tests - No specific part numbers or quantities provided - Notable Requirements: - The ITC is requesting comments on the public interest impact of potential remedial orders (such as exclusion or cease and desist orders) - Input is sought on effects to public health, competitive conditions, U.S. production, and consumers - The focus is on the broader category of melanoma test products and their components, not on procurement of specific items

Description

The U.S. International Trade Commission has received a complaint entitled Certain Melanoma Predictive and Prognostic Tests and Components Thereof, DN 3921. The Commission is soliciting comments on any public interest issues raised by the complaint or complainant's filing pursuant to the Commission's Rules of Practice and Procedure. The complaint alleges violations of section 337 of the Tariff Act of 1930 related to the importation, sale for importation, and sale within the United States of certain melanoma predictive and prognostic tests and components thereof. Comments should address the impact of the requested remedial orders on public health, competitive conditions, production of like articles, and U.S. consumers.

View original listing